The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments

Inclusion Criteria:

• Patient currently is undergoing treatment for cancer

• Patient has menopausal symptoms induced either by surgical or medical (patient ontamoxifen or aromatase inhibitor) interventions for cancer

• > 18 years of age

• Willing to travel to a Legacy Health facility if necessary

• Agree to attend study visits outside of standard of care visits, if needed

• Willing to stop other supplements or medications that are aimed at treating menopausalsymptoms at least 7 days before beginning study treatment

• Willing to engage in pre/post testing and survey/phone calls

Exclusion Criteria:

• Patient is currently undergoing chemotherapy treatment

• < 18 years of age

• Unable to comply with protocol

• Unable to provide written informed consent

• Investigator does not believe study participation is in the best interest of thepatient

• Patient had concurrent menopausal symptoms prior to the start of cancer treatment

• Menopausal symptoms are unrelated to surgical or medical treatment of breast orgynecologic cancers